首页> 外国专利> METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE

机译:急性缺血性中风的治疗方法和药物组合物

摘要

An easily administrable drug treatment to increase the recanalization rate associated with intravenously t-PA would represent a major advance in the acute ischemic stroke (AIS) management. The inventors demonstrate the presence of NETs network in intracranial thrombus extracted during AIS reperfusion procedures. Thrombi are encapsulated by these NETs network, which confer t-PA resistance. In fact, in presence of DNAse 1, t-PA-induced thrombolysisis accelerated, whereas DNAse alone is inefficient. These results suggest that a co-therapy associating t-PA and DNAse 1 may potentialize t-PA efficacy. Accordingly, the present invention relates to a method of treating an acute ischemic stroke (AIS) in a patient in need thereof comprising administering to the patient a therapeutically effective combination of t-PA and DNAse, wherein administration of the combination results in enhanced therapeutic efficacy relative to the administration of t-PA alone.
机译:一种易于管理的药物治疗可提高与静脉t-PA相关的再通率,这将代表急性缺血性卒中(AIS)管理的一项重大进展。发明人证明了在AIS再灌注过程中提取的颅内血栓中存在NETs网络。血栓被这些NET网络封装,赋予t-PA抗性。实际上,在存在DNAse 1的情况下,t-PA诱导的溶栓作用会加速,而仅DNAse效率低下。这些结果表明,联合使用t-PA和DNAse 1的联合疗法可能会提高t-PA的疗效。因此,本发明涉及一种在有需要的患者中治疗急性缺血性中风(AIS)的方法,该方法包括给患者施用t-PA和DNAse的治疗有效组合,其中给予该组合导致增强的治疗功效。相对于单独使用t-PA而言。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号